Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Bonnie Hammer"'
Autor:
Peter Lamb, Seema Kantak, Bryan Glaser, Justin Wetter, Bee-Cheng Sim, Jeff Higaki, Jacob Beal, Sara Ollerman, Dileep Pulukkunat, Mandar Bawadekar, Charles Kaplan, Bonnie Hammer
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Externí odkaz:
https://doaj.org/article/1667f5e92ad147a390c033bc9d07eb14
Autor:
Anna Ritter, Nicholas Marshal, Dileep Pulukkunat, Nikhil Pereira, Alexander Rakhmilevich, Joseph Gawdzik, Jessica Wiwczar, Jason Russell, Laura McCormick, Catherine Aversa, Paul Sondel, Hilario Ramos, Bonnie Hammer, Daniel Pereira
Publikováno v:
Regular and Young Investigator Award Abstracts.
Autor:
Amy K. Erbe, Arika Feils, Zack Rosenkrans, Jessica Wiwczar, Daniel Gerhardt, Bonnie Hammer, Mildred Felder, Mark Bercher, Alina Hampton, Lizzie Frankel, Dan Spiegelman, Noah Tsarovsky, Alexander Rakhmilevich, Jacquelyn Hank, Bryan Glaser, Reinier Hernandez, Roland Green, Paul M. Sondel
Publikováno v:
Cancer Research. 82:2019-2019
Introduction: GD2 is expressed on neuroblastoma, melanomas, small cell lung cancers and sarcomas. While it is expressed minimally on normal tissues, it is expressed on nerve cells and, anti-GD2 (dinutuximab) treatment can cause neuropathic pain. To i
Autor:
Bonnie Hammer
USA TODAY BESTSELLER “Think of this book as your personal guide for moving into the leadership spot you dream about—without losing yourself in the web of workplace lies and half-truths women too frequently fall for.” —Forbes A master class
Autor:
Justin Wetter, Bonnie Hammer, Bryan Glaser, Charles Kaplan, Sara Ollerman, Peter Lamb, Jeff Higaki, Mandar Bawadekar, Bee-Cheng Sim, Pulukkunat Dileep Kumar, Seema Kantak, Jacob Beal
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Tumor cells have been shown to utilize both innate and adaptive checkpoints to evade anti-tumor immune responses. CD47 and PD-L1 are two targets widely expressed on the cell surface of tumor cells and are predicted to coordinately suppress
Autor:
Roland Green, Mildred Felder, Mackenzie Heck, Christopher Massey, Todd E. Barnhart, Bryan Glaser, Mark Bercher, Paul M. Sondel, Gerhardt Daniel Justin, Amy K. Erbe, Arika Feils, Sabrina VandenHeuvel, Bonnie Hammer, Jennifer Dennin, Reinier Hernandez, Jacquelyn A. Hank, Jonathan W. Engle
Publikováno v:
Regular and young investigator award abstracts.
Background Disialoganglioside 2 (GD2) is expressed on neuroblastomas as well as melanomas, small cell lung cancers, and sarcomas. Anti-GD2 mAb (Dinutuximab) can be used to treat these cancers and is part of the standard care for neuroblastoma. While
Autor:
Amy K Erbe, Reinier Hernandez, Daniel Gerhardt, Bonnie Hammer, Mildred Felder, Mark Bercher, Jennifer Dennin, Christopher Massey, Sabrina VandenHeuvel, Arika S Feils, Mackenzie Heck, Jacquelyn A Hank, Bryan Glasser, Roland Green, Paul M Sondel
Publikováno v:
The Journal of Immunology. 204:91.2-91.2
GD2 is expressed on neuroblastomas, as well as melanomas, small cell lung cancers and sarcomas. Anti-GD2 mAb can be used to treat these cancers and is part of the standard care for neuroblastoma. Expressed minimally on normal tissues, GD2 is expresse
Autor:
Bonnie Hammer, Mandar Bawadekar, Matthew Bissen, John Painter, Lauren Lehmann, Francis Qufei Li, Lucas Bailey, Bryan Glaser, Roland Green
Publikováno v:
Cancer Research. 79:563-563
The development of agonistic antibodies that activate T-cell co-stimulatory pathways represents a therapeutic strategy with significant clinical potential. However, challenges remain for the translation from in vitro efficacy to clinical success. OX4
Autor:
Tomac, Bonnie Hammer Illustrations John W. (AUTHOR)
Publikováno v:
Wall Street Journal - Online Edition. 5/4/2024, pN.PAG-N.PAG. 1p.